Dean Kamen
Executive Director and Board Chair,
Advanced Regenerative Manufacturing Institute

Dean Kamen is an inventor, an entrepreneur, and a tireless advocate for science and technology. His roles as inventor and advocate are intertwined—his own passion for technology and its practical uses has driven his personal determination to spread the word about technology’s virtues and by so doing to change the culture of the United States.

As an inventor, he holds more than 440 U.S. and foreign patents, many of them for innovative medical devices that have expanded the frontiers of health care worldwide. While still a college undergraduate, he invented the first wearable infusion pump, which rapidly gained acceptance from such diverse medical specialties as oncology, neonatology, and endocrinology. In 1976, he founded his first medical device company, AutoSyringe, Inc., to manufacture and market the pumps. Following the sale of AutoSyringe, Inc., he founded DEKA Research & Development Corporation to develop internally generated inventions as well as to provide research and development for major corporate clients.

In addition to DEKA, one of Dean’s proudest accomplishments is founding FIRST® (For Inspiration and Recognition of Science and Technology), an organization dedicated to motivating the next generation to understand, use and enjoy science and technology. Founded in 1989, this year FIRST® will serve more than 400,000 young people, ages 6 to 18, in more than 86 countries around the globe. Last year, high-school-aged participants were eligible to apply for more than $50 million in scholarships from over 200 leading colleges, universities, and corporations.

Manufacturing the Future of Biofabrication
BioFabUSA faces two grand challenges.  First, leverage the promise of tissue engineering to alleviate pain, suffering and restore form, function and appearance to the wounded warfighter.  Second, help reinvigorate our nation’s advanced manufacturing capability to drive increased US competitiveness, security and workforce capabilities.

As Americans, we have faced and overcome grand challenges before.  To clothe the country, in the mid-1800’s, textile mills in Manchester, NH produced six-hundred (600) miles of fabric a day.  To save the lives of patients in renal failure, DEKA invented and developed dialysis therapies that have been conducted more than four hundred million (400,000,000) times.  To solve America’s science and technology talent gap, FIRST has inspired over three million (3,000,000) students to engage in STEM since it was founded in 1992.

In some sense, the grand challenges faced by BioFabUSA are old news. The promise of tissue engineering was on the cover of science magazines over twenty years ago.  We have known for years that an investment valley of death meant far too few engineered tissue innovations moved from the lab into patents lives.

To finally overcome these challenges, BioFabUSA’s nationwide partnership was established to make practical the large-scale manufacturing of tissues and tissue related technologies, for the benefit existing industries and growing new ones.  Together, we will manufacture the future of biofabrication.